Annual report
3604.TEDINET S100TT3D
Period2023-04-01 → 2024-03-31
Filed2024-06-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥29.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥30.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥30.1bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥30.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥25.1bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥410m | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥692m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥564m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥825m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥857m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥299m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥623m | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.0bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥402m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥747m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥643m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.4bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥255m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥408m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥766m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥19.5bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥19.5bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥17.2bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥17.1bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥15.6bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥11.8bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥12.2bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.8bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.0bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥5.4bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥4.0bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.5bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.2bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.2bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥592m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥175m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥467m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥978m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥624m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥576m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥705m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥327m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥142m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥250m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥344m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥858m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥444m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥681m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥69.32 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥128.96 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.88 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥236.49 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.91 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,222.32 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,146.87 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,019.15 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥916.85 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥676.18 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 36.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.4% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.1% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.1% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 5.9% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.9% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.5% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 29.7% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.7% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 436 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 444 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 395 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 389 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 376 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥27.5bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥28.7bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥28.4bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥28.9bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥24.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥392m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥655m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥547m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥726m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥954m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥966m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥290m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥535m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥725m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥380m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥502m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥781m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥247m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥17.5bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥17.6bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥16.3bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥16.3bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥15.1bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥11.1bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥11.5bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥6.4bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥6.1bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥5.7bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥5.1bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥4.0bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥538m | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥572m | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥65.65 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥86.63 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥134.79 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥189.87 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.63 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥18 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥12 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥6 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,105.55 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,048.6 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥977.11 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥882.88 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥684.82 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 36.5% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.6% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.8% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.4% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.1% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.6% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.5% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 24.2% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.3% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 6,000,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,000,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,000,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,000,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,000,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 228 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 232 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 239 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 234 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 244 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 32
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥18m |
| Reconciling Itemsreconciling | segment ordinary income | 2023-04-01 → 2024-03-31 | −¥590m |
| Consumerreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥20m |
| Consumerreportable segment | employees | at 2024-03-31 | 73 pure |
| Consumerreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥21.5bn |
| Consumerreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥21.5bn |
| Consumerreportable segment | segment ordinary income | 2023-04-01 → 2024-03-31 | ¥860m |
| Medicalreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥224m |
| Medicalreportable segment | employees | at 2024-03-31 | 293 pure |
| Medicalreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥8.1bn |
| Medicalreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥8.1bn |
| Medicalreportable segment | segment ordinary income | 2023-04-01 → 2024-03-31 | ¥293m |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥243m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥29.6bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥29.6bn |
| —segment total | segment ordinary income | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥22m |
| Reconciling Itemsreconciling | segment ordinary income | 2022-04-01 → 2023-03-31 | −¥559m |
| Consumerreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥21m |
| Consumerreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥21.9bn |
| Consumerreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥21.9bn |
| Consumerreportable segment | segment ordinary income | 2022-04-01 → 2023-03-31 | ¥1.0bn |
| Medicalreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥181m |
| Medicalreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥8.5bn |
| Medicalreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥8.5bn |
| Medicalreportable segment | segment ordinary income | 2022-04-01 → 2023-03-31 | ¥359m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥202m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥30.4bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥30.4bn |
| —segment total | segment ordinary income | 2022-04-01 → 2023-03-31 | ¥1.4bn |
| Consumerreportable segment | employees | at 2024-03-31 | 36 pure |
| Medicalreportable segment | employees | at 2024-03-31 | 169 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,552
| Item | Context | Value | Unit |
|---|---|---|---|
| Other net inv cf | CurrentYearDuration | -5029000 | JPY |
| Net cash provided by used in investment activities | Prior1YearDuration | -705300000 | JPY |
| Net cash provided by used in investment activities | CurrentYearDuration | -575777000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YearDuration | 356000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYearDuration | 220000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YearDuration | 1491483000 | JPY |
| Proceeds from long term loans payable fin cf | CurrentYearDuration | 840000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YearDuration | -906246000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYearDuration | -1309400000 | JPY |
| Repayments of lease obligations fin cf | Prior1YearDuration | -2602000 | JPY |
| Repayments of lease obligations fin cf | CurrentYearDuration | -1363000 | JPY |
| Cash dividends paid fin cf | Prior1YearDuration | -81016000 | JPY |
| Cash dividends paid fin cf | CurrentYearDuration | -93234000 | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration | 857618000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration | -343997000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YearDuration | 22310000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYearDuration | 33845000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration | 349170000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | -293725000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 1105422000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1454593000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1454593000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 1160867000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 5 | |
| Contract liabilities | Prior1YearInstant | 32239000 | JPY |
| Contract liabilities | CurrentYearInstant | 35900000 | JPY |
| Discounted electronically recorded monetary claims | Prior1YearInstant | 262144000 | JPY |
| Discounted electronically recorded monetary claims | CurrentYearInstant | 269134000 | JPY |
| Write downs of inventories | Prior1YearDuration | 10255000 | JPY |
| Write downs of inventories | CurrentYearDuration | -9680000 | JPY |
| Salaries and allowances sga | Prior1YearDuration | 849923000 | JPY |
| Salaries and allowances sga | CurrentYearDuration | 881055000 | JPY |
| Provision for bonuses sga | Prior1YearDuration | 103414000 | JPY |
| Provision for bonuses sga | CurrentYearDuration | 83162000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration | 41943000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 31585000 | JPY |
| Freightage expenses sga | Prior1YearDuration | 2054256000 | JPY |
| Freightage expenses sga | CurrentYearDuration | 1915924000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YearDuration | 1994000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration | 857000 | JPY |
| Provision for directors retirement benefits sga | Prior1YearDuration | 7550000 | JPY |
| Provision for directors retirement benefits sga | CurrentYearDuration | 2077000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | Prior1YearDuration | 69133000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | CurrentYearDuration | 64650000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00614-000ConsumerReportableSegmentsMember | 21882943000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00614-000MedicalReportableSegmentMember | 8520964000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReportableSegmentsMember | 30403907000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YearDuration | 30403907000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E00614-000ConsumerReportableSegmentsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |